Overall, these findings underscore the pivotal roles of the CagA-SQLE-PD-L1 axis in gastric cancer progression and immune evasion, highlighting their potential roles as therapeutic targets in gastric cancer treatment. This evidence concerns the gene S100A8 and gastric cancer.